247.72
前日終値:
$244.17
開ける:
$244.415
24時間の取引高:
1.06M
Relative Volume:
1.12
時価総額:
$15.56B
収益:
$4.44B
当期純損益:
$29.49M
株価収益率:
-13,463.04
EPS:
-0.0184
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+2.80%
1か月 パフォーマンス:
+3.84%
6か月 パフォーマンス:
+46.26%
1年 パフォーマンス:
+130.22%
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
名前
Jazz Pharmaceuticals Plc
セクター
電話
353-1-634-7800
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals Plc
|
247.72 | 15.34B | 4.44B | 29.49M | 1.19B | -0.0184 |
|
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Raymond James | Outperform |
| 2026-02-27 | 開始されました | Barclays | Overweight |
| 2025-11-24 | ダウングレード | UBS | Buy → Neutral |
| 2025-07-15 | 開始されました | Deutsche Bank | Buy |
| 2025-03-07 | アップグレード | UBS | Neutral → Buy |
| 2025-02-26 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | 開始されました | Goldman | Buy |
| 2024-01-03 | 開始されました | Robert W. Baird | Outperform |
| 2023-11-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-29 | 開始されました | Raymond James | Mkt Perform |
| 2023-06-12 | 再開されました | Wells Fargo | Equal Weight |
| 2022-12-09 | アップグレード | Goldman | Neutral → Buy |
| 2022-06-14 | 開始されました | UBS | Buy |
| 2022-04-06 | ダウングレード | Goldman | Buy → Neutral |
| 2021-11-19 | 再開されました | Goldman | Buy |
| 2021-10-07 | 再開されました | Jefferies | Buy |
| 2021-10-05 | 開始されました | Citigroup | Buy |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-05-19 | 再開されました | JP Morgan | Overweight |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-02-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-14 | ダウングレード | Goldman | Neutral → Sell |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | 開始されました | Jefferies | Buy |
| 2020-03-12 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | 開始されました | Goldman | Neutral |
| 2019-08-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | 開始されました | Barclays | Overweight |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2018-12-14 | 開始されました | Wolfe Research | Peer Perform |
| 2018-11-08 | 繰り返されました | B. Riley FBR | Buy |
| 2018-08-08 | 繰り返されました | Stifel | Buy |
| 2018-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | 繰り返されました | H.C. Wainwright | Neutral |
| 2018-03-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース
JAZZ Maintains Rating by Truist Securities -- Price Target Lowered to $254 - GuruFocus
Sleep Apnea Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com
Jazz Pharmaceuticals Holds Steady Near Resistance as Volume Patterns Signal CautionQuality Factor - dars.gov.et
Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus
JAZZJazz Pharmaceuticals plc Options - Finviz
Jazz Pharmaceuticals (JAZZ) Breakout Keeps Valuation In Focus Following Zepzelca Setback And Ziihera Hopes - simplywall.st
Jazz Pharmaceuticals (JAZZ) EVP reports RSU tax withholding and retains 47,911 shares - Stock Titan
Jazz Pharmaceuticals (JAZZ) CEO shares withheld to cover RSU tax obligations - Stock Titan
Jazz Pharmaceuticals (JAZZ) insider RSU tax withholding detailed - Stock Titan
Jazz Pharmaceuticals (JAZZ) CFO reports 3,343-share tax withholding - Stock Titan
Jazz Pharmaceuticals (JAZZ) Price Forecast: Will Breakout Confirm Higher Highs? - FXEmpire
Jazz Pharmaceuticals stock hits all-time high at 243.39 USD - Investing.com
Jazz Pharmaceuticals stock hits all-time high at 243.39 USD By Investing.com - Investing.com UK
Form 144 Jazz Pharmaceuticals Plc For: 1 July By Investing.com - Investing.com Nigeria
Bruce Cozadd files Form 144 to sell shares — Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan
Enterprise value to revenue forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView
Price to earnings forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView
Price to book forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView
Is Jazz Pharmaceuticals (JAZZ) Using AbCellera Deal to Quietly Redefine Its Oncology Strategy? - simplywall.st
3 Overrated Stocks Walking a Fine Line - Yahoo Finance UK
Price to sales forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - TradingView
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks - AOL.com
Erica Jefferson Joins Jazz Pharmaceuticals as Chief Communications Officer - hrtoday.in
JAZZ Forecast — Price Target — Prediction for 2027 - TradingView
Jazz Pharmaceuticals' lung cancer drug setback in late-stage trials: Here's why the stock impact may be more limited than it looks - MSN
Jazz Pharma announces late-stage trial setback for lung cancer therapy - MSN
Jazz Pharmaceuticals Public Limited Company Actuals & Estimates (NASDAQ:JAZZ) - TradingView
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) (NASDAQ:JAZZ) - Seeking Alpha
Jazz Pharmaceuticals (JAZZ) Reframed Zepzelca Growth, Is The Stock Still Below Fair Value? - simplywall.st
Strong Leaders Build Strong Teamsand Strong Teams Change Patients’ LivesJazz Pharmaceuticals - Oncodaily
Jazz Pharmaceuticals PLC (HAM:J7Z) Stock Price, Trades & News - GuruFocus
Jazz Pharmaceuticals (JAZZ) Stock Gets Fair Value Boost As Ziihera Views Split Analysts - Yahoo Finance
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal - Yahoo Finance
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration - Yahoo Finance UK
Will Zepzelca’s Failed LAGOON Trial in Second-Line SCLC Change Jazz Pharmaceuticals' (JAZZ) Narrative? - simplywall.st
JAZZ’s Zepzelca fails to meet primary goal in lung cancer study - MSN
Investor Outlook: Jazz Pharmaceuticals Plc (JAZZ) And Its 14.40% Potential Upside - DirectorsTalk Interviews
Jazz Pharmaceuticals PLC (JAZZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Jazz Pharmaceuticals (JAZZ) Stock Could Be 73% Below Fair Value After Recent Pullback - simplywall.st
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies - Yahoo Finance
A potential billion-dollar deal looks for new ways to beat back cancer - The Business Journals
Jazz and AbCellera sign deal for T-cell engagers in solid tumours - Pharmaceutical Technology
Jazz Pharmaceuticals PLC (JAZZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Institutional Confidence - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Insider Sell: Mark Smith Sells Shares of Jazz Pharmaceuticals PL - GuruFocus
Jazz Pharmaceuticals Plc (JAZZ) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):